Center for Financial Planning’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.5K Hold
115
﹤0.01% 460
2026
Q1
$16K Hold
115
﹤0.01% 438
2025
Q4
$14.1K Hold
115
﹤0.01% 449
2025
Q3
$12.8K Hold
115
﹤0.01% 471
2025
Q2
$12.8K Hold
115
﹤0.01% 440
2025
Q1
$12.9K Sell
115
-23
-17% -$2.37K ﹤0.01% 444
2024
Q4
$12.7K Hold
138
﹤0.01% 394
2024
Q3
$11.6K Buy
138
+38
+38% +$2.9K ﹤0.01% 387
2024
Q2
$6.86K Hold
100
﹤0.01% 430
2024
Q1
$7.33K Hold
100
﹤0.01% 436
2023
Q4
$8.1K Hold
100
﹤0.01% 394
2023
Q3
$7.49K Hold
100
﹤0.01% 384
2023
Q2
$7.71K Hold
100
﹤0.01% 413
2023
Q1
$8.3K Buy
+100
New +$8.28K ﹤0.01% 377
2021
Q1
Sell
-219
Closed -$13K 532
2020
Q4
$13K Hold
219
﹤0.01% 320
2020
Q3
$14K Buy
219
+90
+70% +$6.24K ﹤0.01% 287
2020
Q2
$10K Sell
129
-140
-52% -$10.7K ﹤0.01% 307
2020
Q1
$20K Buy
269
+266
+8,867% +$18.4K 0.01% 257
2019
Q4
$0 Buy
+3
New +$195 ﹤0.01% 459

Other funds holding GILD

Center for Financial Planning's GILD Position: Q2 2026 in Review

Center for Financial Planning held its Gilead Sciences (GILD) position steady in Q2 2026 at 115 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Center for Financial Planning first reported a position in GILD in Q4 2019 and has held it in 19 quarters since. The position peaked at $20K in Q1 2020. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Center for Financial Planning held 115 shares of Gilead Sciences worth $14.5K as of Q2 2026.
  • Center for Financial Planning left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #460 holding.
  • Center for Financial Planning first reported a position in Gilead Sciences in Q4 2019 and has held it in 19 quarters since.
  • Center for Financial Planning's Gilead Sciences position peaked at $20K in Q1 2020.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.